genentech inc said file suit against food and drug administr district court for district columbia over unresolv issu relat genet engin human growth hormon issu said genentech whether eli lilli and recombin human growth hormon and it new recombin growth hormon same drug both drug under review fda sinc 1985 genentech has been market protropin recombin human growth hormon for treat abnorm short children biotechnolog concern said has right seven year exclus market for protropin grant orphan drug status fda orphan drug special categori drug use treat rare diseas genentech said suit seek clarif constitut drug under standard orphan drug act suggest without clarif compani develop orphan drug may not recov develop cost dure period market exclus said lilli growth hormon and it new growth hormon differ slight and produc differ process reuter 